Developers of immunocancer drugs
and allergy disease treatments
and allergy disease treatments
Location: South Korea
Investors 2
| Date | Name | Website |
| - | AJU IB Inv... | ajuib.co.k... |
| - | we venture... | en.weventu... |
Mentions in press and media 3
| Date | Title | Description |
| 20.03.2026 | GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer | SEOUL, South Korea, March 20, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resi... |
| 13.05.2025 | GI Innovation and GI Biome Advance to the Semi-finals of XPRIZE Healthspan with Anti-Aging Potential of GI-102 and GIB-7 Combination Therapy | GI Innovation and GI Biome have been selected as a Top 40 semi-finalist in the XPRIZE Healthspan competition among 600 registered teams from 58 countries Selected as one of 8 teams to pitch at the XPRIZE Investor Summit in New York The team... |
| 22.01.2025 | GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy | SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ -- GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development of GI-102 and ADC pancreatic cancer combination ther... |